tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market

Pharming Group (PHAR) Income Statement

Compare
132 Followers

Pharming Group Income Statement

Last quarter (Q1 2025), Pharming Group's total revenue was €79.09M, an increase of 42.29% from the same quarter last year. In Q1, Pharming Group's net income was €-14.72M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 297.20M€ 245.32M€ 205.62M€ 189.85M€ 228.39M
Gross Profit
€ 252.72M€ 220.10M€ 188.06M€ 169.67M€ 203.06M
Operating Expenses
€ 270.42M€ 225.49M€ 169.83M€ 156.72M€ 120.97M
Depreciation and Amortization
€ 15.51M€ 15.93M€ 13.19M€ 19.61M€ 8.31M
EBITDA
€ 7.19M€ 9.88M€ 33.53M€ 48.78M€ 92.11M
Operating Income
€ -8.32M€ -4.88M€ 18.23M€ 27.84M€ 82.09M
Other Income/Expenses
€ 104.25K€ -7.13M€ -3.25M€ -4.76M€ -18.33M
Pretax Income
€ -8.22M€ -12.01M€ 14.99M€ 22.03M€ 47.47M
Net Income
€ -10.64M€ -10.55M€ 13.67M€ 16.00M€ 37.75M
Per Share Metrics
Basic EPS
€ -0.15€ -0.14€ 0.17€ 0.20€ 0.46
Diluted EPS
€ -0.15€ -0.14€ 0.15€ 0.18€ 0.44
Weighted Average Shares Outstanding
68.92M 65.70M 88.39M 87.64M 85.34M
Weighted Average Shares Outstanding (Diluted)
68.92M 65.70M 88.39M 87.64M 85.34M
Currency in EUR

Pharming Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis